Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolic and antirheumatic activities of 6-methylprednisolone (medrol).

Literature DB >> 13470731

Metabolic and antirheumatic activities of 6-methylprednisolone (medrol).

E W BOLAND, G W LIDDLE.

Abstract

Entities: Chemical

Keywords: ARTHRITIS, RHEUMATOID/therapy; PREDNISOLONE

Mesh：

Substances：

Year: 1957 PMID： 13470731 PMCID： PMC1006965 DOI： 10.1136/ard.16.3.297

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

12 in total

1. Major undesirable side-effects resulting from prednisolone and prednisone.

Authors: A J BOLLET; R BLACK; J J BUNIM
Journal: J Am Med Assoc Date: 1955-06-11

2. The physiological disposition and metabolic fate of hydrocortisone in man.

Authors: R E PETERSON; J B WYNGAARDEN; S L GUERRA; B B BRODIE; J J BUNIM
Journal: J Clin Invest Date: 1955-12 Impact factor: 14.808

3. Adrenal corticoid activities of 6-methyl-delta-hydrocortisone.

Authors: L E BARNES; W W BYRNES; G H LUND; S C LYSTER; M M MEINZINGER
Journal: Proc Soc Exp Biol Med Date: 1957-01

4. Studies of structure-function relationships of steroids: the 2-methyl-corticosteroids.

Authors: G W LIDDLE; J E RICHARD; G M TOMKINS
Journal: Metabolism Date: 1956-07 Impact factor: 8.694

5. The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors: R H SILBER; C C PORTER
Journal: J Biol Chem Date: 1954-10 Impact factor: 5.157

6. The physiological basis for a method of assaying aldosterone in extracts of human urine.

Authors: G W LIDDLE; J CORNFIELD; A G CASPER; F C BARTTER
Journal: J Clin Invest Date: 1955-09 Impact factor: 14.808

7. Biological effects of 9-alpha-fluorohydrocortisone and related halogenated steroids in animals.

Authors: J FRIED
Journal: Ann N Y Acad Sci Date: 1955-05-27 Impact factor: 5.691

8. Explanation of the effect of feeding desiccated thyroid on the incidence of dental caries in the rat.

Authors: E RYAN; S KIRKWOOD
Journal: Science Date: 1955-02-04 Impact factor: 47.728

9. Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties.

Authors: J J BUNIM; M M PECHET; A J BOLLET
Journal: J Am Med Assoc Date: 1955-01-22

10. The determination of urinary steroids. I. The preparation of pigment-free extracts and a simplified procedure for the estimation of total 17-ketosteroids.

Authors: I J DREKTER; A HEISLER; G R SCISM; S STERN; S PEARSON; T H McGAVACK
Journal: J Clin Endocrinol Metab Date: 1952-01 Impact factor: 5.958

5 in total

Metabolic and antirheumatic activities of 6-methylprednisolone (medrol).

1. Major undesirable side-effects resulting from prednisolone and prednisone.

2. The physiological disposition and metabolic fate of hydrocortisone in man.

3. Adrenal corticoid activities of 6-methyl-delta-hydrocortisone.

4. Studies of structure-function relationships of steroids: the 2-methyl-corticosteroids.

5. The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

6. The physiological basis for a method of assaying aldosterone in extracts of human urine.

7. Biological effects of 9-alpha-fluorohydrocortisone and related halogenated steroids in animals.

8. Explanation of the effect of feeding desiccated thyroid on the incidence of dental caries in the rat.

9. Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties.

10. The determination of urinary steroids. I. The preparation of pigment-free extracts and a simplified procedure for the estimation of total 17-ketosteroids.

1. Triamcinolone therapy in rheumatoid arthritis.

2. Triamcinolone in the treatment of rheumatoid arthritis.

3. A CYP21A2 based whole-cell system in Escherichia coli for the biotechnological production of premedrol.

Review 4. Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent.

5. 6-Methyl prednisolone in the treatment of rheumatoid arthritis.